Table 3.
CRH stimulation test results
| Serial No. | Patient | Time from CRH injection (min) | |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| −15 | 0 | 5 | 10 | 15 | 20 | 30 | 40 | 60 | 80 | 90 | 100 | 120 | |||
| 1 | 2010-1 | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| 2 | 2010-1 | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| 3 | 2012-1 | SeC, nmol/L | 218 | 194 | 192 | 233 | 399 | 555 | 751 | 705 | 604 | – | – | – | – |
| ACTH, ng/L | 22 | 21 | 39 | 45 | 52 | 43 | 43 | 50 | 39 | – | – | – | – | ||
| SeCΔ (%) | – | – | −12 | +7 | +83 | +155 | +244 | +223 | +177 | – | – | – | – | ||
| ACTHΔ (%) | – | – | +77 | +105 | +136 | +95 | +95 | +127 | +77 | – | – | – | – | ||
| 4 | 2012-1 | SeC, nmol/L | 174 | 135 | 138 | 175 | – | 324 | 298 | 251 | 242 | – | – | – | – |
| ACTH, ng/L | 48 | 42 | 66 | 79 | – | 75 | 71 | 73 | 58 | – | – | – | – | ||
| SeCΔ (%) | – | – | −21 | +1 | – | +86 | +71 | +44 | +39 | – | – | – | – | ||
| ACTHΔ (%) | – | – | +38 | +65 | – | +56 | +48 | +52 | +21 | – | – | – | – | ||
| 5 | 2012-1 | SeC, nmol/L | 650 | 660 | 679 | 804 | – | 889 | 937 | 946 | 936 | – | – | – | – |
| ACTH, ng/L | 74 | 71 | 118 | 133 | – | 156 | 150 | 145 | 145 | – | – | – | – | ||
| SeCΔ (%) | – | – | +4 | +24 | – | +37 | +44 | +46 | +44 | – | – | – | – | ||
| ACTHΔ (%) | – | – | +59 | +80 | – | +111 | +103 | +96 | +96 | – | – | – | – | ||
| 6 | 2013-1 | SeC, nmol/L | 674 | 755 | – | – | 853 | – | 947 | – | 751 | – | 604 | – | 779 |
| ACTH, ng/L | 80 | 98 | – | – | 184 | – | 144 | – | 56 | – | 40 | – | 83 | ||
| SeCΔ (%) | – | – | – | – | +27 | – | +41 | – | +11 | – | −10 | – | +16 | ||
| ACTHΔ (%) | – | – | – | – | +130 | – | +80 | – | –30 | – | –50 | – | +4 | ||
| 7 | 2013-1 | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| 8 | 2013-1 | SeC, nmol/L | – | 100 | – | – | – | – | 374 | 624 | 750 | 977 | – | 975 | – |
| ACTH, ng/L | – | 18 | – | – | – | – | 26 | 58 | 132 | 104 | – | 70 | – | ||
| SeCΔ (%) | – | – | – | – | – | – | +274 | +524 | +650 | +877 | – | +875 | – | ||
| ACTHΔ (%) | – | – | – | – | – | – | +44 | +222 | +633 | +478 | – | +289 | – | ||
| 9 | 2014-2 | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| 10 | 2014-1 | SeC, nmol/L | 54 | 57 | – | – | 67 | – | 71 | 60 | 56 | – | 97 | – | 74 |
| ACTH, ng/L | 11 | 13 | – | – | 18 | – | 13 | 11 | 16 | – | 18 | – | 16 | ||
| SeCΔ (%) | – | – | – | – | +24 | – | +31 | +11 | +4 | – | +80 | – | +37 | ||
| ACTHΔ (%) | – | – | – | – | +64 | – | +18 | 0 | +45 | – | +64 | – | +45 | ||
| 11 | 2014-2 | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| 12 | 2015-2 | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| 13 | 2015-2 | SeC, nmol/L | 645 | 605 | – | – | 550 | – | 506 | 498 | 482 | – | 608 | – | 711 |
| ACTH, ng/L | 58 | 51 | – | – | 45 | – | 48 | 44 | 49 | – | 68 | – | 67 | ||
| SeCΔ (%) | – | – | – | – | −15 | – | −22 | –23 | –25 | – | −6 | – | +10 | ||
| ACTHΔ (%) | – | – | – | – | −22 | – | −17 | –24 | –16 | – | +17 | – | +16 | ||
| 14 | 2016-1 | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| 15 | 2016-1 | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| 16 | 2018-1 | SeC, nmol/L | 637 | 609 | – | – | 587 | – | 618 | 638 | 638 | – | 706 | – | 711 |
| ACTH, ng/L | 63 | 57 | – | – | 53 | – | 61 | 65 | 68 | – | 74 | – | 76 | ||
| SeCΔ (%) | – | – | – | – | −8 | – | –3 | 0 | 0 | – | +11 | – | +12 | ||
| ACTHΔ (%) | – | – | – | – | −16 | – | –3 | +3 | +8 | – | +17 | – | +21 | ||
| 17 | 2019-2 | – | – | – | – | – | – | – | – | – | – | – | – | – | |
First column displays the patient number. Second column includes: year of diagnosis, 1: female, 2: male.
SeC, serum cortisol.